For brands planning to export shampoo products to the U.S. market, understanding and complying with FDA requirements for shampoos is the primary prerequisite to ensuring smooth customs clearance and avoiding legal risks.
In 2026, with the full implementation of the Cosmetics Modernization Regulatory Act (MoCRA), the U.S. Food and Drug Administration (FDA) has significantly strengthened its regulation of personal care products such as shampoos, making compliance mandatory rather than optional.
This article provides an in-depth analysis of the 2026 FDA requirements for shampoos, covering core areas including product classification, facility registration, ingredient safety, labeling regulations, and recall mechanisms.
It aims to help you mitigate risks and advance steadily as you enter the U.S. market.
I. Is Shampoo Classified as a Cosmetic or a Drug? Classification Determines the Regulatory Path
In the United States, the regulatory pathway for shampoo is determined solely by its intended use.
This is the first critical dividing line in understanding FDA requirements for shampoo.
1.Cosmetic Shampoos
Most daily shampoos, conditioners, and styling products are classified as cosmetics, provided that their claims are limited to cleansing, beautifying, or improving appearance. Examples include “cleanses hair,” “adds shine,” and “smoothes hair strands,” all of which are cosmetic claims. Cosmetic shampoos do not require pre-market approval by the FDA, but must comply with all regulatory requirements under MoCRA.
2.Drug Shampoos
Shampoos that claim to treat or prevent disease, or affect the structure or function of the human body, are regulated as drugs by the FDA. Typical examples include:
- Anti-dandruff shampoos: containing anti-dandruff ingredients such as zinc pyrithione, salicylic acid
- Anti-hair loss shampoos: claiming to “treat hair loss” or “prevent baldness”
- Medicated shampoos: claiming to “relieve scalp conditions”
According to 21 CFR 358.760, if an anti-dandruff shampoo contains a topical analgesic ingredient, the label must state “Anti-Dandruff/Anti-Itch Shampoo” or “Anti-Seborrheic/Anti-Itch Shampoo.”
⚠️ Risk Warning: Shampoos containing active pharmaceutical ingredients but lacking FDA approval may face detention, refusal of import, or even Warning Letters from the FDA. In the past year alone, the FDA refused nearly 3,000 “cosmetic” products that lacked the required approvals.
II. Core Compliance Requirements Under the MoCRA Framework
MoCRA represents the most significant reform to the U.S. cosmetic regulatory framework in decades, granting the FDA far stronger enforcement authority. Below are the core provisions that must be implemented to meet the 2026 FDA requirements for shampoo products:
1. Facility Registration and Product Listing
Under MoCRA, all facilities that manufacture or process shampoo for sale in the U.S. (including overseas OEM/ODM factories) must register with the FDA and renew registration every two years. Meanwhile, each shampoo product must be listed via FDA Form 5067, with required submission information including:
- Responsible Person name (manufacturer, packer, or distributor listed on the label)
- Product category code (e.g., 06F2 for non-coloring rinse-off shampoo)
- Ingredient list (by INCI name)
- Label image (optional but recommended)
Product listing may be submitted through the Cosmetics Direct electronic portal. Any changes to formulation or labeling must be updated in the product listing.
2. Responsible Person System
MoCRA clearly defines the Responsible Person as the manufacturer, packer, or distributor listed on the product label.
The Responsible Person bears legal responsibility for product safety substantiation, adverse event reporting, and regulatory compliance.
The label must include contact information for a Responsible Person located in the U.S. to receive consumer adverse event notifications.
3. Safety Substantiation
Under Section 601 of the FD&C Act, cosmetics without adequate safety evidence may be deemed “adulterated.” Brands or manufacturers must maintain or be able to provide:
- Safety assessments for each ingredient in the formulation
- Toxicological risk assessments of the finished product
- Exposure and margin of safety analysis
III. Ingredient Safety: Prohibited and Restricted Substances
The 2026 FDA requirements for shampoo products focus on the following areas with regard to ingredient safety:
1.Formaldehyde and Formaldehyde-Releasing Agents
Formaldehyde is a recognized carcinogen that can cause health issues such as respiratory irritation and skin allergies. Although the FDA planned to issue a proposal to ban formaldehyde and formaldehyde-releasing agents (e.g., those used in hair straightening products) as early as 2023, the deadline for this proposal has been postponed multiple times as of January 2026. At present, the FDA has stated that this rule “remains a priority for the agency,” but no formal ban has been issued.
Nonetheless, multiple independent studies and epidemiological data have clearly linked formaldehyde in hair straightening products to an increased risk of uterine cancer, ovarian cancer, breast cancer, and uterine fibroids. States such as California have adopted stricter restrictions.
2.Fragrance Allergens
Pursuant to MoCRA requirements, the FDA plans to issue a Notice of Proposed Rulemaking (NPRM) on fragrance allergen disclosure in May 2026, mandating the labeling of specific fragrance allergens on cosmetic labels.
3.Asbestos in Talc
The FDA plans to establish and mandate standardized testing methods for the detection and identification of asbestos in cosmetics containing talc.
IV. Labeling Requirements: The First Line of Defense for Compliance
Non-compliant labeling is one of the most common reasons shampoo products are detained at customs. Under the 2026 FDA requirements for shampoo, labels must include the following elements:
- Product identification: a clear statement of what the product is (e.g., “shampoo”)
- Net quantity: using US customary units (ounces/pounds)
- Ingredient list: listed in descending order of concentration by INCI name
- Manufacturer/distributor information: name and address of the Responsible Person located in the U.S.
- Warning statements: where necessary (e.g., if containing specific allergens)
- All information must be in English.
For drug-classified shampoos (such as anti-dandruff shampoos), labels must also comply with specific requirements of the OTC monographs. For example, 21 CFR 358.760 stipulates that the “Directions” section of anti-dandruff shampoos must include specific wording such as “relieves” or “controls” dandruff symptoms.
V. Adverse Event Reporting and Mandatory Recall Mechanisms
MoCRA has significantly expanded the FDA’s enforcement authority, a section that brands must prioritize under the 2026 FDA requirements for shampoo products.
1.Serious Adverse Event Reporting
If a shampoo causes a serious adverse event (such as hospitalization, severe injury, or death), the Responsible Person must report it to the FDA within 15 business days of receiving the information.In addition, an annual summary report of all adverse events (including minor reactions such as rashes) must be submitted to the FDA.
2.FDA Mandatory Recall Authority
MoCRA grants the FDA statutory authority to order mandatory recalls of cosmetic products for the first time. The FDA may intervene when a product:
- Is in violation: adulterated or misbranded
- Poses a significant health risk: may result in serious adverse health consequences or death upon use
The recall process includes:
FDA issues a written notice → requests the Responsible Person to conduct a voluntary recall → if the party fails to cooperate, the FDA may order an immediate halt to distribution → the Responsible Person may request a hearing → a final decision on mandatory recall is made after the hearing.
⚠️ Failure to comply with an FDA order may result in injunctive relief or even criminal prosecution.
VI. Special Considerations for Overseas Manufacturers
For shampoo manufacturers located outside the United States, the 2026 FDA requirements for shampoo include the following special provisions:
- A U.S. Agent must be designated to communicate with the FDA.
- Facility registration requirements apply equally: Overseas manufacturers must register under MoCRA.
- Product listing is not exempt: Every shampoo product must be listed in the U.S.
- The FDA may inspect overseas facilities to verify compliance of manufacturing lines.
Summary: Key Requirements for Shampoo by the FDA in 2026
| Compliance Dimensions | Key Requirements | Implementation Timeline / Notes |
| Product Classification | Distinction between Cosmetics and Drugs | Drugs must comply with the OTC monograph; otherwise, they may be deemed an “unapproved new drug”. |
| Facility Registration | Both overseas and domestic manufacturers are required to register with the FDA. | Renew every two years. |
| Product Listing | Submit via FDA Form 5067 | Update product information after changes; confirm the accuracy of product listings annually. |
| Safety Proof | Maintain safety assessments for ingredients and finished products. | The FDA may require the submission of evidence; a lack thereof may result in the product being deemed “adulterated”. |
| Label Compliance | Include responsible person information, ingredients, net content, etc. | Pharmaceutical products must comply with the specific requirements of the OTC monograph. |
| Adverse Event Reporting | Serious adverse events must be reported within 15 days. | Submit an annual summary of adverse events. |
| Recall Mechanism | The FDA has the authority to mandatorily recall high-risk products. | Cooperating with FDA investigations is crucial. |
For shampoo brands and manufacturers, the 2026 FDA requirements for shampoo products are no longer optional, but a mandatory threshold for entering the U.S. market.
Selecting manufacturing partners that are MoCRA‑ready, possess FDA‑registered facilities, and maintain a complete compliance system will be the key safeguard for brands to develop steadily in an increasingly stringent regulatory environment.
If you are interested in creating your own shampoo brand, please feel free to contact us anytime.
